Home ยป UBE2S Inhibits Autophagy Through PI3K/AKT/mTOR Signaling, Promoting Cisplatin Resistance in Ovarian Cancer
Pubmed Latest

UBE2S Inhibits Autophagy Through PI3K/AKT/mTOR Signaling, Promoting Cisplatin Resistance in Ovarian Cancer

by satcit
written by satcit

https://pubmed.ncbi.nlm.nih.gov/38115063

UBE2S inhibits autophagy through PI3K/AKT/mTOR signaling, promoting cisplatin resistance in ovarian cancer.

You may also like

“Addressing Modifiable Risk Factors to Improve Cardiovascular Outcomes:...

“Modifiable Risk Factors’ Impact on Cardiovascular Outcomes: A...

“Semaglutide May Improve Heart Failure in Obese Patients...

Semaglutide’s Potential Beneficial Effects on Heart Failure with...

“Semaglutide May Lower Heart Failure Hospitalization Risk in...

“Semaglutide May Reduce Cardiovascular Risks in Heart Failure...

“Methemoglobinemia Outbreak in Japanese Neonatal ICU and Maternity...

“New Perspectives on Medical Ethics: A Commentary in...

“Balancing Probability and Precision in Designing Future ARDS...

“Evaluating Doxycycline Postexposure Prophylaxis for Preventing Sexually Transmitted...

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.

@2023 - All Right Reserved.